A patient prepares to take the first of two combination pills, mifepristone, for a medication abortion during a visit to a clinic in Kansas City, Kan., Oct. 12, 2022. The Supreme Court is being asked to reverse an appellate ruling that would cut off mail-order access to a drug used in the most common method of abortion in the United States. In an appeal filed Friday, Sept. 8, 2023, Danco Laboratories, the manufacturer of mifepristone, argued that federal judges should not second-guess the Food and Drug Administration's approval of the drug or the conditions under which it is dispensed. The Biden administration also was expected to file an appeal. (AP Photo/Charlie Riedel, File)
Featured Photo Galleries
